Gilead Sciences | 당기 순이익



Net Income 변화 날짜
AbbVie USD 1.29B 1.31B 2025-03
Agios Pharmaceuticals USD -96523000 1.04B 2024-12
ALKERMES USD 367.07M 274.69M 2024-12
Alnylam Pharmaceuticals USD -83763000 27.81M 2024-12
Amgen USD 627M 2.2B 2024-12
Biogen USD 266.7M 121.8M 2024-12
BioMarin Pharmaceutical USD 124.94M 18.86M 2024-12
Bristol-Myers Squibb USD 2.46B 2.38B 2025-03
Eli Lilly USD 2.76B 1.65B 2025-03
Gilead Sciences USD 1.78B 529M 2024-12
GlaxoSmithKline GBP 1.62B 1.21B 2025-03
Glaxosmithkline GBP 414M 472M 2024-12
Incyte USD 158.2M 43.01M 2025-03
J&J USD 11B 7.57B 2025-03
Merck USD 5.08B 1.34B 2025-03
Moderna USD -971000000 149M 2025-03
Neurocrine Biosciences USD 103.1M 26.7M 2024-12
Novartis USD 2.82B 371M 2024-12
Pfizer USD 2.97B 2.56B 2025-03
PTC Therapeutics USD -65886000 40.77M 2024-12
Regeneron Pharmaceuticals USD 808.7M 109M 2025-03
Sanofi EUR 1.87B 1.37B 2025-03
Sarepta Therapeutics USD 159.05M 125.44M 2024-12
United Therapeutics USD 322.2M 20.9M 2025-03
Vertex Pharmaceuticals USD 913M 132.4M 2024-12



Gilead Sciences 당기 순이익 - 현재 값, 이력 데이터, 예측, 통계, 차트 및 경제 달력 - May 2025.